An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis
-
Published:2021-09-28
Issue:12
Volume:56
Page:3068-3077
-
ISSN:0268-3369
-
Container-title:Bone Marrow Transplantation
-
language:en
-
Short-container-title:Bone Marrow Transplant
Author:
Jimenez Jimenez Antonio M.ORCID, De Lima MarcosORCID, Komanduri Krishna V., Wang Trent P.ORCID, Zhang Mei-Jie, Chen Karen, Abdel-Azim Hisham, Abid Muhammad BilalORCID, Aljurf Mahmoud, Alkhateeb Hassan, Assal AmerORCID, Bacher Ulrike, Baron FrédéricORCID, Battiwalla Minoo, Beitinjaneh Amer, Bejanyan NelliORCID, Bhatt Vijaya RajORCID, Byrne Michael, Cahn Jean-Yves, Cairo MitchellORCID, Castillo PaulORCID, Copelan Edward, DeFilipp ZachariahORCID, Perez Miguel Angel Diaz, Elsawy MahmoudORCID, Gale Robert Peter, George Biju, Grunwald Michael R.ORCID, Hildebrandt Gerhard C.ORCID, Hogan William J.ORCID, Kanakry Christopher G., Kansagra AnkitORCID, Kharfan-Dabaja Mohamed A.ORCID, Khera Nandita, Krem Maxwell M., Lazaryan AleksandrORCID, Maakaron JosephORCID, Martino Rodrigo, McGuirk JosephORCID, Michelis Fotios V., Milone GiuseppeORCID, Mishra AsmitaORCID, Murthy Hemant S., Mussetti Alberto, Nathan SunitaORCID, Nishihori TaigaORCID, Olsson Richard F., Palmisiano Neil, Patel SagarORCID, Saad Ayman, Seo SachikoORCID, Sharma AkshayORCID, Solh MelhemORCID, Verdonck Leo F., Wirk BaldeepORCID, Yared Jean A.ORCID, Litzow MarkORCID, Kebriaei PartowORCID, Hourigan Christopher S.ORCID, Saber Wael, Weisdorf DanielORCID
Publisher
Springer Science and Business Media LLC
Subject
Transplantation,Hematology
Reference32 articles.
1. Sorror ML, Maris MB, Storb R, Baron F, Sandmaier BM, Maloney DG, et al. Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT. Blood. 2005;106:2912–9. 2. Koreth J, Schlenk R, Kopecky KJ, Honda S, Sierra J, Djulbegovic BJ, et al. Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials. JAMA. 2009;301:2349–61. 3. Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study. Blood. 2000;96:4075–83. 4. Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH, et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood. 2010;116:354–65. 5. Dholaria B, Savani BN, Hamilton BK, Oran B, Liu HD, Tallman MS, et al. Hematopoietic cell transplantation in the treatment of newly diagnosed adult acute myeloid leukemia: an evidence-based review from the American society of transplantation and cellular therapy. Transplant Cell Ther. 2021;27:6–20.
Cited by
15 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|